Trial Profile
A clnical study to assess inhibitory effect of bepotastine besilate OD tablet to compare with fexofenadine hydrochloride and pseudoephedrine hydrochloride combination tablet in patients with cedar pollinosis in the OHIO Chamber.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Nov 2013
Price :
$35
*
At a glance
- Drugs Bepotastine (Primary) ; Fexofenadine/pseudoephedrine
- Indications Tree pollen hypersensitivity
- Focus Therapeutic Use
- 10 Nov 2013 Status changed from not yet recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 02 Jun 2013 New trial record